Adaptimmune Therapeutics PLC (ADAP)
1.19
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
1.195
0.00 (0.00%)
After-Hours: 20:00
Adaptimmune Therapeutics Cash from Operations (Quarterly): -14.68M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -14.68M |
| September 30, 2023 | -45.16M |
| June 30, 2023 | -43.76M |
| March 31, 2023 | -37.28M |
| December 31, 2022 | 2.042M |
| September 30, 2022 | -48.16M |
| June 30, 2022 | -41.25M |
| March 31, 2022 | -54.40M |
| December 31, 2021 | 133.93M |
| September 30, 2021 | -45.20M |
| June 30, 2021 | -31.46M |
| March 31, 2021 | -46.54M |
| December 31, 2020 | -29.22M |
| September 30, 2020 | -16.32M |
| June 30, 2020 | -24.92M |
| March 31, 2020 | 16.86M |
| December 31, 2019 | -12.53M |
| September 30, 2019 | -29.61M |
| Date | Value |
|---|---|
| June 30, 2019 | -34.17M |
| March 31, 2019 | -36.20M |
| December 31, 2018 | -31.68M |
| September 30, 2018 | 9.939M |
| June 30, 2018 | -35.36M |
| March 31, 2018 | -47.28M |
| December 31, 2017 | -21.36M |
| September 30, 2017 | 13.49M |
| June 30, 2017 | -18.01M |
| March 31, 2017 | -28.44M |
| December 31, 2016 | 2.37M |
| September 30, 2016 | -15.37M |
| June 30, 2016 | -16.49M |
| March 31, 2016 | -18.68M |
| September 30, 2015 | -0.2667M |
| December 31, 2014 | -2.051M |
| September 30, 2014 | -13.10M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-54.40M
Minimum
Mar 2022
133.93M
Maximum
Dec 2021
-21.15M
Average
-31.46M
Median
Jun 2021
Cash from Operations (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana PLC | 0.4825M |
| Autolus Therapeutics PLC | -24.83M |
| TC BioPharm (Holdings) PLC | -- |
| Bicycle Therapeutics PLC | -47.29M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 68.20M |
| Cash from Financing (Quarterly) | 0.074M |
| Free Cash Flow | -145.76M |
| Free Cash Flow Per Share (Quarterly) | -0.0682 |
| Free Cash Flow to Equity (Quarterly) | -15.50M |
| Free Cash Flow to Firm (Quarterly) | -15.50M |
| Free Cash Flow Yield | -60.85% |